Chargement en cours...

Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease

BACKGROUND: Individuals with chronic bronchitis or chronic obstructive pulmonary disease (COPD) may suffer recurrent exacerbations with an increase in volume or purulence of sputum, or both. Personal and healthcare costs associated with exacerbations indicate that therapies that reduce the occurrenc...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cochrane Database Syst Rev
Auteurs principaux: Poole, Phillippa, Sathananthan, Kavin, Fortescue, Rebecca
Format: Artigo
Langue:Inglês
Publié: John Wiley & Sons, Ltd 2019
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6527426/
https://ncbi.nlm.nih.gov/pubmed/31107966
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD001287.pub6
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!